|

Parkinson's Disease Clinical Trials in Los Angeles, CA

21 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3<1 mi
Terazosin and Parkinson's Disease Extension StudyPhase 2<1 mi
Terazosin Effect on Cardiac Changes in Early Parkinson's DiseasePhase 2<1 mi
Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst StimulationN/A<1 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 3<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)Phase 2<1 mi
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's DiseasePhase 1/2<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—<1 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/3<1 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 411 mi
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseasePhase 120 mi
A Study of Buntanetap in Participants With PDPhase 2/329 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—36 mi
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseasePhase 236 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 236 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 245 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 345 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 445 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.